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Abstract
Post-traumatic inflammation is formed by molecular and cellular complex mechan-
isms whose final goal seems to be injured tissue regeneration.
In the skin -an exterior organ of the body- mechanical or thermal injury induces the
expression of different inflammatory phenotypes that resemble similar phenotypes
expressed during embryo development. Particularly, molecular and cellular mechan-
isms involved in gastrulation return. This is a developmental phase that delineates
the three embryonic germ layers: ectoderm, endoderm and mesoderm. Conse-
quently, in the post-natal wounded skin, primitive functions related with the embryo-
nic mesoderm, i.e. amniotic and yolk sac-derived, are expressed. Neurogenesis and
hematogenesis stand out among the primitive function mechanisms involved.
Interestingly, in these phases of the inflammatory response, whose molecular and
cellular mechanisms are considered as traces of the early phases of the embryonic
development, the mast cell, a cell that is supposedly inflammatory, plays a key role.
The correlation that can be established between the embryonic and the inflamma-
tory events suggests that the results obtained from the research regarding both
great fields of knowledge must be interchangeable to obtain the maximum
advantage.
Introduction
Inflammation is considered the fundamental scientific principle underlying the practice
of surgery [1]. Although nowadays the main role of the inflammatory response is due
to its close relationship with illness and therefore is pathological, maybe the origin of
these mechanisms have a different meaning, even physiological. Thus, we have pre-
viously proposed that the evolutive phases of the post-traumatic inflammatory response
may have a trophic meaning for the injured tissue [2]. Based on this supposition it
would not be unreasonable to consider most of the inflammatory mechanisms as rem-
nants of ancestral times when life depended on their trophic activity [3]. Fortunately,
these mechanisms do not only represent remnants from the past in the case of injury,
but also assume their ancient phenotypes in favor of survival [2,3].
When acute tissue damage is produced by a mechanical or thermal harmful stimulus,
both types of energy are etiologically involved, either in tissue injury production,
usually a wound [4], or in triggering an inflammatory response [5]. Cellular lesions are
irreversible in the wounds produced by mechanical and thermal energy since necrosis
is produced [5]. Until recently, necrosis has often been viewed as an accidental and
uncontrolled cell death process. Nevertheless, growing evidence supports the idea that
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necrotic cell death may also be programmed [6]. Cellular signaling events have been
identified to initiate necrotic destruction that could be blocked by inhibiting discrete
cellular processes [7].
The most relevant mechanisms culminating in cell necrosis correspond to mitochon-
drial dysfunction and ATP depletion; loss of intracellular ion homeostasis, with osmo-
tic swelling and oxidative stress; activation of degradative hydrolases, and degradation
of cytoskeletal proteins with disruption of cytoskeletal integrity [8]. Surprisingly
enough, this list of mechanisms also correspond to what occurs in the acute inflamma-
tory post-injury response [2,3]. It seems that, in response to injury, cells can develop
mechanisms that would play a defensive role, i.e. inflammation, and which could favor
reversing the alterations until their inadequate expression would make them harmful, i.
e. cell death [9]. Hence, at a specific moment in time, the pathophysiological mechan-
isms, i.e. cellular response to injury, become a pathogenic mechanism, i.e. producers of
cell death [3]. Thus, it could be considered that the cells can “escape” death in attacked
tissues. Taken all together these mechanisms would in turn constitute the post-injury
inflammatory response [2,3,10].
Wounds and Inflammation
The skin is protecting the organism against physical, chemical and microbial impacts
of the environment [11,12]. It represents the second largest organ in adult humans,
only surpassed by the vascular system [12]. The skin, consists of an outer squamous
epithelium, the epidermis and its appendages (sweat glands, pilosebaceous follicles and
nails) and two inner layers of connective tissues, the dermis and the hypodermis
[11,13]. Therefore, a wound that includes the three layers of this organ would injure
its parenchyma, or epidermis, and the stroma, which is made up of dermis and hypo-
dermis (Figure 1).
The inflammatory response expressed by this organ after a wound can have exogen-
ous and endogenous inducers [9]. Noxious mechanical or thermal stimuli as exogenous
signals and cellular necrosis, as endogenous signals, can initiate the inflammatory
response [14,15]. Thus, mechanical or thermal energy, as an exogenous damage/alarm
signal [14,15], have the ability to produce a wound, i.e. damage, as well as initiate an
inflammatory response, i.e. alarm.
Today, the role that inflammation “per se” plays in cutaneous wound repair is most
likely very limited. Thus, it is accepted that inflammation is only another component
of the repair process. Thus, the common description of wound repair evolution
includes three classic types: Inflammation, new tissue formation and remodeling
[16-19]. However, some authors describe four healing phases: Hemostasis, inflamma-
tion, repair and remodeling [20] and even five phases: Hemostasis, inflammation, cellu-
lar migration and proliferation, protein synthesis and wound contraction and
remodeling [21].
Nowadays, we need integrative pathophysiology to integrate all the new knowledge to
understand the inflammatory response because the distance between new molecular
knowledge and every day patient care is increasing. Now we need to understand cell
biology and genetics of inflammation better to identify gene and metabolic targets in
order to modulate aspects of the inflammatory response [22]. We have therefore
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proposed that the inflammatory wound response recapitulates ontogeny and phylogeny
through trophic mechanisms of increasing complexity to the injured tissue [2,10].
Phases and phenotypes during wound repair
The inflammatory response that is induced in the injured tissue could be described as
a succession of three overlapped phases, during which the phenotypes of metabolic
progressive complexity related to the use of oxygen are expressed. Each one of these
phases emphasizes the trophic role of the mechanisms developed in the damaged tis-
sue. Hence, nutrition by diffusion predominates the first phase; trophism is mediated
by inflammatory cells in the second phase; and finally blood circulation and oxidative
metabolism play the most significant nutritive roles in the third phase [10].
Since these trophic mechanisms are of increasing complexity, progressing from
anoxia to total specialization in the use of oxygen to obtain usable energy, it could be
speculated that they represent the successive reappearance of the stages that took
place during the evolution of life without oxygen on Earth from ancient times. In this
sense, the inflammatory response not only could recapitulate phylogeny, but also onto-
geny, through the successive expression of phenotypes that have a trophic meaning for
the injured tissue [2,3,10] (Figure 2).
The successive inflammatory phenotypes are expressed mainly in the interstitial
space. Therefore, the interstitial space always seems to be the battlefield for inflamma-
tion, whether it is due to trauma [2,3], infection [3] or tumors [23-25].
Figure 1 Consequences of noxious -mechanical and thermal energy- over the skin organ, that is
formed by epidermis (parenchyma), and dermis and hypodermis (stroma). A: Adipocyte; F: Fibroblast;
K: Keratinocyte; L: Lymphatic capillary; M: Macrophage; MC: Mast cell; N: Neuron; V: Post-capillary venule;
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In the first or immediate phase of the inflammatory response, interstitial hydroelec-
trolytic alterations stand out. This phase has been referred to as the nervous phase,
because the sensory (pain and analgesia) and motor alterations (contraction and
relaxation of smooth and skeletal muscle fibers) respond to the injury. Particularly, the
vasomotor response -with vasoconstriction and vasodilation- is responsible of the
ischemia-reperfusion phenomenon, with the subsequent excessive production of reac-
tive oxygen and nitrogen species (ROS/RNS) that causes oxidative and nitrosative
stress in the injured tissue. In this phase, during the progression of the interstitial
edema, the space between epithelial cells and capillaries increases, and the lymphatic
circulation is simultaneously activated (circulatory switch) [2,10].
In the following intermediate or immune phase of the inflammatory response, the
tissues which have undergone ischemia-reperfusion suffer an immunological activation.
In addition, they are infiltrated by inflammatory blood-born cells, particularly leuko-
cytes. In order to infiltrate the interstitial space, bacteria takes advantage of the chemo-
tactic call, which activates and induces the recruitment of blood cells. In the tissue
which suffers oxidative and nitrosative stress, symbiosis of the leukocytes and bacteria
Figure 2 The inflammatory response which is developed after skin injury is divided into evolutive
vascular phenotypes and phases. Ischemia-reperfusion (I/R), leukocytic (L) and angiogenic (A)
phenotypes are successively expressed during the vascular inflammation. The injured tissue losses its
normal structure and acquires functional autonomy during ischemia-reperfusion and leukocytic phenotype
expression. Then, when the angiogenic phenotype is progressively expressed, the tissue is re-structured
and specialized. In the immediate nervous phase, depolarization and repolarization of cell membranes
would be the key pathophysiological mechanism. During the immune phase, the transient synthesis of
adhesion molecules favors cellular and bacterial translocation. Lastly, in the endocrine phase the skin tries
to recover its parenchymatous structure, or epithelium (regeneration), as well as its stroma or connective
tissue (scarring).
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for extracellular digestion by enzyme release, i.e. fermentation, and by intracellular
digestion, i.e. phagocytosis, produces enzymatic stress. Furthermore, macrophages and
dendritic cells take advantage of the lymphatic circulation activation, and migrate
through it until reaching the lymph nodes, where they activate lymphocytes [2,3].
During the third phase of the inflammatory response, angiogenesis permits numerous
substances, including hormones, to be transported by the blood circulation. For this
reason, it has been considered that the predominance of angiogenesis during the last
phase of the inflammatory response would allow for calling it the endocrine phase.
Although the final objective of the angiogenic phenotype is to form new mature vessels
for oxygen, substrates and blood cells, other functions could be carried out before the
new mature vessels are formed. Thus, angiogenesis could have antioxidant and antien-
zymatic properties, favoring the resolution of the inflammation as well as wound repair
by epithelial regeneration and scarring. Therefore, in this phase the new formed tissue
is structured, specialized and matures by remodeling [2,3,10] (Figure 2).
The three overlapped trophic phases of the post-traumatic inflammatory response
could also be named, by their corresponding length, as acute, subacute and chronic,
respectively. The acute phase is characterized by the quick molecular infiltration of the
interstitial space that would for favoring the establishment of a trophic axis based in
the interstitial fluid flow. In the following or subacute phase, the cellular infiltration of
the interstitial space predominates. In this phase, the invasion of the interstitium by
blood cells would create another trophic axis based on a hypothetical enzymatic diges-
tive ability that is assumed by the leukocytes in the injured tissue. Finally, it could be
interpreted that through the confluence in the interstitial space of both trophic axes,
molecular and cellular, the appropriate metabolic conditions would be generated so
that tissue repair takes place during the last so-called chronic phase of the inflamma-
tory response.
Embryonic bases of inflammation: The amnion and the yolk sac
The inflammatory response could recapitulate ontogeny through the expression of the
two hypothetical trophic axes, molecular and cellular, in the interstitial space of the
injured tissue.
We have previously proposed the hypothesis that inflammation would represent the
debut during post-natal life of ancestral biochemical mechanisms that were used for
normal embryonic development. The re-expression of these old mechanisms, with a
prenatal solvent path, are perhaps inappropriate and hard to recognize since they are
anachronistic during post-natal life and because they are established in a different
environmental medium [3,26].
The early mammalian embryo already has the ability to manage fluids in the intersti-
tial space. In the human blastocyst, the inner cell mass or embryoblast, differentiates
into two layers, the hypoblast and epiblast. The epiblast is the source of all three germ
layers and develops within a small cavity named amniotic cavity [27]. At the early
stages of pregnancy, amniotic fluid consists of a filtrate of maternal blood. That is why
in this period drugs taken by the mother can enter the amniotic fluid by diffusion
across the placenta [28]. Amniotic fluid is an essential component for fetal develop-
ment and maturation during pregnancy [29]. During these stages, amniotic fluid is a
Aller et al. Theoretical Biology and Medical Modelling 2010, 7:37
http://www.tbiomed.com/content/7/1/37
Page 5 of 32
bioactive medium actively secreted by the cells lining the amniotic cavity and as gesta-
tion progresses it includes significant volume of fetal urine [30] (Figure 3).
Body fluid is distributed among three major fluid spaces: Intracellular fluid, intersti-
tial fluid and plasma. Nevertheless, the fluid distribution in each of these compart-
ments is dramatically different in the fetus compared to the adult. Particularly, the
amniotic fluid that surrounds the fetus may be considered an extension of the extracel-
lular space of the fetus [31]. Thus, the lymphatic system plays an essential role in the
regulation of fluid distribution between the plasma and the interstitial fluid and, prob-
ably with the amniotic fluid [31]. It could also be hypothesized that similar functions,
i.e. development and maturation, that the amniotic-lympathic-interstitial fluid axis has
in the embryo, could have interstitial edema and activated lymphatic circulation (circu-
latory switch) in the traumatized tissue.
The yolk sac is the final destination of migrating visceral endoderm cells, that in turn
are derivatives of the hypoblast (Figure 3). The yolk sac begins to form during gastrula-
tion [32]. The visceral yolk sac expands and blood islands -structures consisting of
hematopoietic progenitors surrounded by a loose network of endothelial cells- appear
[32]. Endothelial cell precursors associated with blood islands differentiate and coalesce
Figure 3 Schematic representation of the early mammalian embryo during gastrulation . The
extraembryonic mesoderm (EM) is represented surrounding the amniotic cavity (A) and the yolk sac cavity
(Y). Between the epiblast (E) and the hypoblast (H) the mesoderm internalizes (IM) by epithelial-
mesenchymal transition. On top of the figure, some of the characteristics of the amniotic axis are
summarized. On the other hand, on the bottom, some of the characteristics of the yolk sac axis are
exposed.
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to form a primitive circulation bed, which later connects to the embryo via the vitelline
vessels [32,33].
Mammalian development requires the rapid de novo formation of embryonic blood
cells to support embryonic and fetal growth prior to the establishment of the adult
hematopoietic system. The very first blood cells to appear in the embryonic circulation
arise in the extraembryonic yolk sac [34]. Particularly, primitive macrophages first
develop in the yolk sac [35]. As the embryo develops, newly formed hematopoietic
stem cells are found in the aorta-gonad-mesonephros region, then in the fetal liver,
thymus and spleen and lastly, for adult hematopoiesis, in the bone marrow [36]. The
yolk sac suffers a rapid involution following completion of their hemopoietic and
angiogenic functions [37] (Figure 4).
Thus, the yolk sac-hematopoietic-angiogenic axis coordinates blood cell differentia-
tion and vessel formation and plays an essential role supporting embryonic and fetal
growth [32]. It could also be hypothesized that a similar trophic cellular axis is devel-
oped by the traumatized patient.
The confluence during mammalian development of the amniotic-interstitial fluid axis
and the yolk sac-hematopoietic-angiogenic axis could be one essential factor to drive
gastrulation (Figure 5). Although the details of gastrulation differ among different spe-
cies, the cellular mechanisms involved in gastrulation are common to all animals. After
induction of the germ layers, the blastula, composed by pluripotent stem cells, is trans-
formed by gastrulation movements into a multilayered embryo, including ectoderm,
endoderm and mesoderm with head, trunk and tail rudiments [38]. During the interna-
lization process, cells of the mesoderm move through the blastopore under the ecto-
derm. Mesoderm, the middle or interstitial germ layer, gives rise to hematopoietic,
endothelial, heart, skeletal muscle and connective tissues [38].
In the current review we suggest that in the traumatized tissue both rudimentary and
hypothetical trophic axes could be re-expressed with a similar aim: the creation of a
specialized tissue once again. If so, probably during damaged tissue repair, a similar set
of morphogenetic cell behaviors are used as in gastrulation, including a series of
Figure 4 Schematic representation of the gastrulating embryo under the hypothetical influence of
an amniotic-interstitial fluid-neurogenic axis (A) and yolk sac-hematopoietic-angiogenic axis (Y).
EM. Extraembryonic mesoderm. IM: intra-embryonic mesoderm.
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changes in cell motility, cell shape and cell adhesion. This post-traumatic recreation of
embryonic processes in the adult tissues is a hypothesis that would be supported by
the recent findings about pluripotent stem resident cells in specialized tissues [36,39].
Stem cells with pluripotent/multipotent capacity were thought to be restricted to the
early embryonic stages. However, recent evidence challenged this idea by confirming
the presence of pluripotent/multipotent stem cells in adult tissues and organs. These
cells may participate in cellular turnover and the rebuilding pool of the tissue circum-
stances such as tissue injury [39]. However, their expression in the post-natal body
under the influence of multiple anomalous environmental factors could induce patho-
logical actions associated with tissue reparation.
It has been accepted that the impairments or pathologies associated with wounded
tissue repair during post-natal life have an interstitial origin because it is supposedly
in this space, which is successively occupied by the mesoderm and then, by the con-
nective tissue, where the hypothetical embryonic trophic axes are re-expressed after
trauma. Maybe, this is the reason why the alterations are common in terms of those
structures that occupy the tissue space equivalent to the interstitial space, known as
the stroma. Particularly, the vascular, blood and lymphatic, and nervous inflamma-
tory alterations stand out. These inflammatory changes have been grouped for their
study in pathological axes that are predominantly expressed in the interstitial space
(Figure 6).
Given the confluence of the two rudimentary trophic axes in the injured tissue, we
have supposed that the underlying intention is to carry out a similar phenomenon to
gastrulation. Therefore, it is possible that the resulting vasculo-nervous inflammatory
Figure 5 Hypothetical embryonary interstitial confluence of amniotic and yolk sac trophic axis to
induce gastrulation.
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alterations represent morphogenetic processes related to this crucial step in early
embryogenesis.
Pathological axes of inflammation
The inappropriate expression of the inflammatory phenotypes induces evolutive post-
traumatic complications. Normally, the abnormal post-traumatic inflammatory pheno-
types are predominantly expressed in the vasculo-nervous structures and, for this rea-
son, their pathophysiological mechanisms play the main role in the study of wound
repair complications.
Pathological axis of vascular inflammation
The concept of the inflammatory response as distributed in the successive phases of
ischemia-reperfusion, leukocytic infiltration and angiogenesis [40], is based on the nor-
mal microcirculatory, lymphatic and blood changes suffered by the injured tissue. Con-
sequently, the inappropriate expression of these vascular inflammatory phenotypes,
either by excess or by defect, is an obligatory reference (Figure 6).
* Edema The abnormal expression of the ischemia-reperfusion phenotype during
repair can produce disturbances in ion transport associated with cellular dysfunction.
There is increasing evidence that conditions characterized by an intense local inflam-
matory response are associated with abnormal ion transport [41]. Inflammatory media-
tors which influence ion transport are bradykinin, leukotriens, cytokines, thrombin,
and transforming growth factor (TGF). They trigger the release of specific messengers,
like prostaglandins, nitric oxide and histamine which alter the ion transport function
through specific receptors, intracellular second messengers and protein kinases [41].
Figure 6 Schematic representation of the pathological axes expression during vascular
inflammation, which is developed in the interstitial space of the injured tissue. c: capillary; ec:
epithelial cell; eo: eosinophils; f: fibroblast; l: lymphatic vessel; leu: leucocytes; lym:lymphocyte; mc: mast cell;
mØ: macrophage; p: platelets and fibrin; pe: pericyte; sc: stem cell; v: post-capillary venule.
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It has been stated that small fluctuations in cell hydration or cell volume act as a
potent signal for cellular metabolism and gene expression [42]. Also, the exposure of
cells to higher osmolarity results in the secretion of pro-inflammatory cytokines and
extends normal macrophage half-life [43].
Interstitial edema causes a steady separation of the cells from the capillaries and
widens the diffusion distance for oxygen and nutrients, favors the insufficiency of the
lymphatic circulation and reduces tissue defense mechanisms leading to susceptibility
to infections [3]. Also, interstitial flow is important for lymphangiogenesis [44]. The
interstitial fluid flow associated with edema, even though it can be extremely slow, can
have important effects on tissue morphogenesis and function, cell migration and differ-
entiation and matrix remodeling, among other processes [45,46]. Insights into the
mechanisms linking mechanical forces to cell and tissue differentiation pathways are
important for understanding many diseases, including inflammation [46]. Abnormally
increased interstitial flow rates can occur during inflammation and can also trigger
fibroblasts to differentiate or remodel the extracellular matrix, contributing to the
development of tissue fibrosis [44,45].
The impaired function or formation of lymphatic vessels after trauma, could be asso-
ciated with lymphedema, which is characterized by interstitial fluid accumulation. Lym-
phedema can lead to increased susceptibility to infections, impaired wound healing and
chronic swelling [47].
Limiting swelling is extremely important because the injured area cannot return to
normal until swelling is gone. In musculoeskeletal injuries this is best accomplished
with the “RICE” technique, which involves Rest, Ice, Compression and Elevation [48].
* Coagulation When post-capillary venular membranes become permeable to complex
molecules, including coagulation factors, the extravasation of fluids lead to interstitial
coagulation. Cellular interstitial infiltration of the injured tissue is favored by the action
of intrinsic and extrinsic components of the coagulation cascades. This results in the
production of thrombin, which catalyzes the conversion of fibrinogen of intravascular
origin to fibrin [21,49]. In most pathophysiological situations, it seems that the activa-
tion of both coagulation and complement cascades occurs simultaneously [50]. Com-
plement and coagulation systems are organized into proteolytic cascades which are
composed of serine proteases belonging to the chymotrypsin family. An explanation
for the structural and functional similarities between the clotting and complement sys-
tem is that they originate from a common ancestral developmental-immune cascade
[51]. Thus, the functional linkages between development, hemostasis and immunity in
vertebrates would be explained [50,51].
Mechanical and thermal injuries are conditions predisposed to thrombosis [21]. The
mechanisms underlying this increased tendency for thrombus formation are, in part,
related to the procoagulant properties of the inflammatory mediators produced and
released as a response to injury [50]. The complement system contributes significantly
to thrombosis by directly enhancing blood clotting properties, by augmenting the
inflammatory response, which in turn potentiates inflammation [52].
Inadequate fibrin formation is associated with impaired wound healing. Any process
that removes fibrin from the wound will disrupt the formation of the extracellular
matrix and consequently will also delay wound healing [53]. Mast cells strategically
located in the vicinity of blood and lymph vessels as well as nerve fibers, are among
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the first responders to the stimuli that initiate inflammation [50,54]. While initially
mast cells were identified as only participating in allergic responses, it is now clear that
they participate in other phenomena such as wound healing and fibrosis [54,55]. Parti-
cularly, they contribute to hemostasis through the expression of tissue plasminogen
activator and heparin production, thereby preventing uncontrolled local activation of
the coagulation system [50].
* Exudation Chronic wound fluid is biochemically different from acute wound fluid.
Chronic wounds may produce large amounts of exudate as a by-product of inflamma-
tion that contains elevated levels of enzymes. Exudate from chronic wounds has been
shown to impede or block the proliferation of key cells in the wound healing process,
such as keratinocytes, fibroblasts and endothelial cells [56].
* Suppuration The formation of yellow, milky-yellow, greenish yellow or white-yellow
pus characterizes suppuration or purulent wound inflammation [5]. In addition to the
enzymes released by granulocytes during the process of phagocytosis and bacterial kill-
ing, the bacteria themselves produce a number of exoenzymes that cause tissue
destruction as well as infection localization. Particularly, almost all Staphylococcus aur-
eus strains have the ability to secrete an array of enzymes including nucleases, pro-
teases, lipases, hyaluronidase and collagenase [57]. Matrix metalloproteases would also
collaborate in the development of enzymatic stress in the acute inflammatory tissue
injury [58]. Pus mainly contains necrotic tissue debris and dead neutrophils. When the
collection of pus is localized, an abscess is established [57].
Phagocytosis of bacteria typically accelerates neutrophil apoptosis, which ultimately
promotes the resolution of infection [59]. Although neutrophil apoptosis is critical for
granulocyte homeostasis and the resolution of inflammation, many pro-inflammatory
molecules extend the survival of polymorphonuclear leukocytes during the initial stages
of the inflammatory response. However, some bacterial pathogens alter neutrophil
apoptosis to survive and thereby cause disease [60].
Colonization is defined as the presence of replicating bacteria and adherent microor-
ganism without tissue damage. However critical colonization is a novel concept that
states that the bacterial burden in the chronic wound does not elicit the typical symp-
toms of an infection, but delays healing [61,62].
Acute lymphangitis is often the consequence of a purulent wound inflammation. It is
mostly caused by Staphylococcus pyogenes or Streptococci. Acute lymphangitis is recog-
nizable as linear erythematous streak extending from the primary lesion, i.e. wound,
toward the regional lymph nodes [63,64].
Lymph nodes are essential for the initiation of immune responses by creating an
environment in which lymphocytes and antigen-presenting cells can optimally interact
[65]. Antigen-presenting cells as dendritic cells, macrophages and mast cells, first reach
the subcapsular sinus and then, move into the paracortex where they aggregate around
high-endothelial venules [65,66]. These venules allow the active immigration of T and
B lymphocytes from the blood into the paracortex compartment of the lymph node
[65,67]. However, wound infection by pyogenic bacteria frequently causes nodular lym-
phangitis with nodular subcutaneous swelling along the involved lymph nodes [63].
* Granuloma Within hours of wounding, neutrophils are attracted to the wound site,
followed by monocytes, which mature into macrophages as they invade tissues [68]. In
some invertebrates, mesenchymal cells, endothelial cells or fibroblast-like cells can
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transform into macrophages [35]. In vertebrates, macrophages are involved in modulat-
ing the inflammatory process during the pathogenesis and resolution of tissue injury
and inflammation [59,69,70].
Macrophages have remarkable plasticity that allows them to efficiently respond to
environmental signals and change their phenotype [35,70,71]. Three macrophage popu-
lations based on three different homeostatic activities have been proposed: Host
defense, wound healing and immune regulation [71]. Foreign bodies are indigestible
particles and the macrophages form a granuloma around it. In some cases macro-
phages can fuse with each other to form “giant cells” that encapsulate the foreign body
[9].
* Granulation tissue and remodeling Angiogenesis is closely associated with granula-
tion tissue formation and remodeling as the newly forming cellular complex must be
supplied with oxygen and nutrients [72]. Excessive angiogenesis participates in the for-
mation of granulation tissue, starting about three or four days after injury. The main
cell types driving the excessive generation of the new tissue are macrophages, endothe-
lial cells, fibroblasts and keratinocytes [17]. Mast cells also play a role in coordinating
neovascularization in the wound [54].
Angiogenesis is regulated by numerous “classic” factors: Vascular endothelial growth
factor (VEGF), fibroblast growth factor-2 (FGF-2), transforming growth factors (TGFs),
angiopoietins, platelet-derived growth factor (PDGF), and thrombospondin-1 and
angiostatin. “Non classic” endogenous stimulators of angiogenesis include erythropoie-
tin, angiotensin II, endothelins, adrenomedullin, adipokines (leptin, adiponectin), neu-
ropeptide-Y, vasoactive intestinal peptide (VIP) and substance P [73,74]. They act in
synergy to stimulate endothelial cell function during angiogenesis in tissue repair [74].
As granulation tissue forms in the healing wound, the vascular cells, intermingle with
the provisional matrix, which is composed mainly of fibrin, fibronectin and vibronectin
[74]. Then, the new blood vessels associated with fibroblast and macrophages replace
the fibrin matrix with granulation tissue, which forms a new substrate for keratinocyte
migration [17,21].
Remodeling begins two to three weeks after injury and lasts for a year or more. A
framework of collagen and elastin fibers replaces the granulation tissue and produces
progressive tissue sclerosis [75,76]. Finally, most of the endothelial cells, with macro-
phages and fibroblasts undergo apoptosis, leaving a mass that contains few cells and
consists mostly of collagen and other extracellular-matrix proteins [21].
Pathological axis of neuronal inflammation
The inflammatory mechanisms also develop a fundamental role in the production of
post-traumatic pain.
* Inflammatory pain Inflammatory pain is associated with sensitization of the noci-
ceptive system. Central sensitization represents an enhancement in the function of
neurons and circuits in nociceptive pathways caused by increases in membrane excit-
ability and synaptic efficacy. It also reduces inhibition and is a manifestation of the
remarkable plasticity of the somatosensory nervous system in response to inflammation
[77]. To induce central sensitization, the noxious stimulus must be intense, repeated
and sustained. Peripheral tissue injury is not necessary, although the degree of noxious
stimulation that produces frank tissue injury almost always induces central sensitiza-
tion [77,78].
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Peripheral inflammation induces a phenotypic switch in primary sensory neurons
that comprises a change in their neurochemical character and properties due to altera-
tions in transcription and translation [77]. However, it could be considered that the
inflammatory pain pathogeny is phase-specific. Thus, after the initial electrical phase,
with upregulation of ionic channel expression in the nociceptive circuits, which causes
spontaneous neural firing [78,79], the following would be an immune phase. The lead-
ing role of this phase would be played by the cytokines and immune cells acting as
pain mediators and modulators [80,81]. Lastly, in an endocrine phase, neurotrophic
factors, including nerve growth factor (NGF), brain-derived neurotrophic factor
(BDNF) and neurotrophins 3 and 4, would be associated with structural neural remo-
deling [77,82].
An immediate component of the stress response to pain is the efferent nervous
response, which is mediated by the somatic motor and autonomic nervous system [83].
The somatic motor response usually consists in the withdrawal of the affected part of the
body from the source of irritation. Withdrawal reflexes are the simplest centrally orga-
nized response to painful stimuli [77,84]. Furthermore, the fight-or-flight response is the
behavioral response to a threat, in which the somatic motor response stands out [83].
With respect to the autonomic nervous system, both the sympathetic and parasym-
pathetic nervous systems, participate in the acute inflammatory response [83]. Catecho-
lamines are found in adrenergic neurons, but their highest concentration is found in
the peripheral presynaptic nerve terminals. After depolarizing the stimulation of these
nerves, rapid secretory release of stored catecholamines occurs. Besides the adrenome-
dullary chromaffin cell and neuron derived catecholamines, lymphocytes and phago-
cytes represent a third category of catecholamine-producing cells [85].
In addition, the inflammatory reflex of Tracery is a pathway in which the autonomic
system detects the presence of inflammatory stimuli and modulates inflammation. Par-
ticularly, afferent signals are transmitted to the brain, via the vagus nerve, which acti-
vates a reflex response that culminates in efferent vagus nerve signaling termed the
“cholinergic anti-inflammatory pathway” [86].
Also, by anterograde inflammatory signals, neural cells contribute to local tissue
responses. Noxious stimuli cause nerves to release neuropeptides in the injured tissue, i.
e. substance P and Calcitonin gen related peptide (CGRP). When released into injured
tissues, neuropeptides contribute to the pro-inflammatory responses against injury. The
evidence that neuropeptides contribute to inflammation includes changes in endothelial
cell shape, leading to capillary leak, smooth muscle cell relaxation leading to vasodilata-
tion, mast cell degranulation leading to histamine, serotonine, proteolytic enzymes and
growth factor release, induction of inflammatory cell chemotaxis, increase expression of
adhesion molecule and increase cytokine and growth factor production [87-90]. Experi-
mental and clinical research has shown that excessive neuropeptide activity induces exu-
berant inflammation in hypertrophic scars [89]. Moreover, the functional impotence of
the somatic motor system, which controls voluntary movements, i.e. functio laesa, favors
vascular blood and lymphatic stasis and interstitial edema [48].
* Complex Regional Pain Syndrome type I Complex Regional Pain Syndrome type I
is formerly identified as “reflex sympathetic dystrophy”. This syndrome is the new term
for “causalgia” that always coexists with documented nerve injury [91]. Complex Regio-
nal Pain Syndrome type I causes chronic pain, skin hypersensitivity, vasomotor
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instability with hyperemia, swelling and trophic alterations. It develops in the extremi-
ties mostly after minimal injury and it has been proposed that most of their features
are explicable by small-fiber dysfunction [92]. Ectopically generated ongoing activity in
afferent fibers conducted antidromically could generate neurogenic inflammation in
the peripheral tissues, consisting of arteriolar vasodilation by release of CGRP and sub-
stance P, and postcapillary venular plasma extravasation by release of substance
P [93,94]. Nonetheless, these peripheral inflammatory changes cannot be seen indepen-
dently of the changes in the central nervous system, including the spinal cord. Both,
the central and peripheral nervous system interact with each other via afferent and
efferent signals, some of which may not be electrical but hormonal signals or by
changes of axoplasmic transport [94].
The inflammatory mesenchyma: A round-trip ticket
Fetal wounds heal by regenerating normal epidermis and dermis with restoration of the
extracellular matrix architecture, strength and function [22,95]. Also adult partial-
thickness wounds are repaired by regeneration, i.e. replication of similar cells. In con-
trast, however, adult full-thickness wounds repair by connective scar tissue [56]. There-
fore, the prognosis of extensive and deep wounds is not entirely satisfactory because of
scar formation and the loss of normal function and skin appendages [96]. As a result,
reducing the formation of scars and reestablishing the normal anatomy and function of
the skin and its appendages have become the aim of regenerative medicine research
[95,96] (Figure 7).
Figure 7 Influence of the pathological axis of neuronal and vascular inflammation in the skin
parenchyma (keratinocytes) and stroma (fibroblast). C: Arterial capillary; ECM: Extracellular matrix; F:
Fibroblast; K: Keratinocyte; MC: Mast cell; MØ: Macrophage; N: Neuron; V: Vein;
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The spectrum of scarring includes normal scars, hypertrophic scars and keloids [97].
Hypertrophic scars are often red, inflamed, itchy and even painful. They generally
regress spontaneously within one month to years after the initial injury [97-99]. Keloid
scars are also raised, erythematous and often pruritic, however, they extend beyond the
original wound boundaries and rarely regress over time [97,98,100].
Recently, the role of mast cells in wound repair and the remodeling process have
been attracting attention. Mast cell proteases may provoke matrix degradation; hista-
mine stimulates fibroblast migration and thus may contribute to wound healing regula-
tion [101]. Particularly, keloids and hypertrophic scars have a fourfold increase in the
number of mast cells compared with normal skin. In addition, hypertrophic scar mast
cells release more histamine than normal skin mast cells after stimulation by substance
P [102].
Although after the traumatism, vascular and neuronal inflammation are the main
clinical manifestations, it must not be forgotten that the principal cells that constitute
the skin organ, or parenchyma, are the keratinocytes, and the fibroblasts, whose pri-
mary function is to establish, maintain and modify the connective skin stroma [103]
(Figure 7).
In the human body the fibroblasts form a heterogeneous collection of mesenchymal
cells [103-105] and they are the principal cellular constituents of connective tissues
[103]. Skin fibroblasts constitute a heterogeneous population of contractile (myofibro-
blasts, pericytes, smooth muscle cells), pro-inflammatory, highly proliferative, proangio-
genic and profibrogenic cells [103,106]. Also, in the hypodermis the connective tissue
has the ability to accumulate lipids, i.e. adipose cells [103].
Fibroblasts are mesodermal-derived cells and perhaps this embryonic origin could
justify their great postnatal plasticity. The mesodermal cells of the embryo participate
in the extraembryonary structures, including the corion, the amnios and the yolk sac
[36]. Also, in the embryonic mesoderm “blood islands”, develop. They consist of ery-
throid cells and surrounding endothelial cells which are formed in the vascular plexus
of the yolk sac [36,107]. The differentiation of amnion from the epiblast occurs before
gastrulation and the specification of the three germ layers and cells from the amniotic
fluid show stem cell characteristics although most of the properties reported suggest
that these cells are more similar to mesenchymal stem cells than to amnion epithelial
cells [27]. The major role of the mesodermal cells and their ability to differentiate
from the first stages of embryonic development allow for considering them as the cell
protype that should be resorted to when the repair of any tissue in the body is needed
[36]. And for this reason, perhaps the post-traumatic inflammatory response has the
same intentions, namely, to use the embryonic mesodermal phenotype with a thera-
peutic objective.
If the post-traumatic tissue repair is based on the re-expression of metabolic, histolo-
gic and functional conditions that made the first stages of embryo development possi-
ble, then the fibroblast would play a fundamental role in this repair process. In fact,
this cell is recognized as a mesoderm or embryonic trace and perhaps the most quali-
fied cell for re-expressing this original phenotype [108] (Figure 8).
Local fibroblasts residing in the skin are considered the most prominent source of
myofibroblasts [106,109]. However, a variety of other precursor cells contribute to the
myofibroblast population, depending on the nature of the injured tissue and the
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particular microenvironment [106]. Activated myofibroblasts are generated from a vari-
ety of sources, including resident mesenchymal cells, epithelial and endothelial cells via
the epithelial/endothelial mesenchymal transition as well as from circulating fibroblast-
like cells called fibrocytes, derived from bone-marrow stem cells [103-112]. In addition
circulating monocytes have the capacity to differentiate into non-phagocyte i.e.
mesenchymal cells and endothelial cells [113].
The reason why the myofibroblast is attractive to a broad scientific and clinical audi-
ence is due to the large panel of cells that can develop this phenotype upon activation.
It appears that myofibroblasts can be recruited from whatever local cell type and it is
suitable for rapidly repairing injured tissue [106]. Fibroblast can be induced to acquire
Figure 8 Main role of the mesenchymal cells in the inflammatory interstitium.
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the myofibroblast phenotype during wound repair. Then, the myofibroblast, by virtue
of its ability to express high levels of a-smooth muscle actin, cytokines and extracellu-
lar matrix, is expected to play key roles in the post-traumatic inflammatory skin
response [104].
Several days after injury a subset of wound fibroblast can differentiate into myofibro-
blast which are responsible for repopulating the wounded area in parallel to angiogen-
esis, thus forming the granulation tissue [2,21,99]. Also, myofibroblast are responsible
for wound contraction. However, to highlight the fact that contractile cytoskeleton is
not a feature of normal tissue fibroblast, Boris Hinz introduced the term “proto-myofi-
broblast” for stress fiber-containing, but a-smooth muscle actin-negative fibroblast that
would consist of the early granulation tissue and preorganize the provisional extracel-
lular matrix [106].
Gastrulation is the first major shape change of the developing embryo and cell-direc-
ted mechanical forces have a critical role [114]. Contraction of the actin cytoskeleton,
driven by nonmuscle myosins and regulated by the Rho family GTPases, is a recurring
mechanism for controlling morphogenesis throughout development, from gastrulation
to cardiogenesis [115-117]. Visualizing the location of nonmuscle myosin by immunos-
taining strongly suggests the role of myosin in regulating tension and compression
during gastrulation [116]. The presumed mechanical effect is that myosin is causing
the outer or apical surface to contract. Individual mesoderm cells constrict apically and
leave the epithelium in a process known as ingression. Simultaneously, a loss of ten-
sion around the inner surface is produced. This causes the cell layer to buckle inwards
leading to invagination [115,116].
Granulation tissue is then repopulated with fibroblasts to produce a more densely
collagenous extracellular matrix which is more akin to the matrix found in interstitial
stroma [118]. Recently, it has been demonstrated that subcutaneous granulation tissue
induced by a large foreign body is a source of adult stem cells. This granulation tissue
is derived from a local resting stem cell pool, particularly from dedifferentiate pericytes
[119].
Tissue remodeling requires the removal of granulation tissue and maturation of col-
lagen is oxygen dependent. Indeed increasing wound oxygenation results in increased
collagen deposition and tensile strength [120]. However, hypoxia benefits the expan-
sion, differentiation, adhesion, growth factor secretion and regenerative potential of
mesenchymal stem cells derived from subcutaneous adipose tissue [121].
The synthesis and deposition of extracellular matrix largely occurs in response to
mechanical signals mediated via cell receptors [115,116], cytokines and growth factors
[118]. Particularly, the extracellular matrix can bind to and release certain growth fac-
tors, i.e. FGF-2, VEGF and PDGF, thereby exerting direct control over their activity
[118].
The notochord is an embryonic structure that could be a candidate for comparison
with this phase of tissue remodeling. This anatomical structure of the embryo domi-
nates early morphogenesis as a source of molecular signals i.e. growth factors, and
later as a mechanical structure [122].
Degradation and remodeling of the extracellular matrix by proteases, particularly
matrix metalloproteases (MMPS) is a key feature of re-epithelialization and tissue
remodeling [17]. Interestingly enough, the differentiation of an antifibrotic
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myofibroblast phenotype in response to tissue injury could inhibit collagen production
as well as fibroblast proliferation. The fact that fibrosis may be due to a loss in antifi-
brotic properties rather than due to the activation of a fibrotic process suggests that, in
normal tissues, active mechanisms to suppress fibrosis may be constitutively important
in maintaining tissue homeostasis [104].
The phenotypic changes suffered by the keratinocytes during re-epithelialization sug-
gest a partial epithelial-mesenchymal transition (Figure 7). Following the completion of
wound-repair, keratinocytes revert to their mesenchymal-like phenotype to epithelial
phenotype [18,123]. During the immediate keratinocyte response to the injury, one of
the principal transducer signals can be electrical, by depolarization and hyperpolariza-
tion of the plasma membranes. Free ion movement occurs suddenly through mem-
brane pores, which can either be opened or closed in response to a great variety of
gating mechanisms, including voltage gating [124].
A cut in the skin produces a current that can be detected. This “injury” potential
represented the short circuiting of a transepithelial potential that generated electrical
field vectors as current flowed from areas of high resistivity, namely, with intact tight
junctions, to the cut, where resistivity is low. Thus, the short circuiting of transepithe-
lial potentials can be sensed over 1-2 mm from the wound and will persist until repair
and re-epithelialization is complete [124,125].
One to two days after injury, the migration of keratinocytes from the epidermis at
the wound edge and from injured appendages is produced [18,21]. Epithelial cell
migration requires the disassembly of desmosomes and hemidesmosomes, which pro-
vide anchorage of the basal keratinocytes with neighboring epithelial cells and the
underlying basement membrane respectively [126]. This disassembly and keratinocytes
migration require cross-talk between growth factors, MMPs, integrins and structural
proteins. In addition to lamellipodia extension, basal keratinocytes leapfrog over the
basal cell near the wound [126].
The keratinocytes that are behind the leading edge in larger wounds proliferate and
mature and finally restore the barrier function of the epithelium [18,21,49]. This could
involve the proliferation of epidermal stem cells [18]. The proteins involved in re-
epithelialization include various extracellular matrix proteins and their receptors,
proteases and cytoskeletal proteins. Growth factors that are known to stimulate wound
re-epithelialization include hepatocyte growth factor (HGF), FGF, TGF-a and heparin-
binding epidermal growth factor (HB-EGF). The signaling pathways initiated by these
growth factors activate the transcription factor signal transducer and activator of
transcription 3 (STAT 3) and activator protein (AP)-1, which help to regulate wound
re-epithelialization [18].
It has long been known that chronic wounds are at risk for neoplastic progression.
Chronic inflammation is a major risk for various types of cancer [127]. The risk of
squamous cell carcinoma is markedly increased, suggesting that keratinocytes are espe-
cially vulnerable to malignant transformation [17]. The main difference between the
migration of wound keratinocytes and cancer cells is the complete epithelial-mesenchy-
mal transition that is frequently seen in cancer cells [128]. The epithelial-mesenchymal
transition that is associated with cancer progression is considered a type 3 epithelial-
mesenchymal transition [123]. Carcinoma cells undergoing a type 3 epithelial-
mesenchymal transition lose all cell-cell contacts, acquire a fibroblast-like morphology
Aller et al. Theoretical Biology and Medical Modelling 2010, 7:37
http://www.tbiomed.com/content/7/1/37
Page 18 of 32
and express mesenchymal marker proteins. These processes resemble those that are
activated during early embryogenesis (type 1) [123], and after skin injury (type 2)
[123,128].
There is now broad evidence that tumor cells depend on metabolic alterations for
their continued growth and survival, and that these changes make cancer cells pecu-
liarly addicted to the rapacious uptake of glucose and glutamine [129,130]. This means
that glucose and glutamine supply most of the carbon, nitrogen, free energy and redu-
cing equivalents needed to support cell growth and division [124,131]. Proliferating
cells during tumor progression, immune response or wound repair, have a similar
metabolic regulation that allows for maximizing their rate of anabolic growth and pro-
liferation [131]. This type of cell metabolism directed at growth and proliferation, is
also efficiently used during mammal embryogenesis [129]. This is why it has been pro-
posed that the alterations in metabolic control during wound repair and tumorigenesis
may result from reverting to an embryonic program [131]. If so, inflammation, a com-
mon process to wound repair, tumorigenesis and embryogenesis could have a trophic
purpose for the cells [2,10,24,40,132,133].
When emulating gastrulation is not enough to heal wounds by regeneration
In the current review we have proposed that the inflammatory response employed by
the adult for wound repair could resemble the early phases of embryogenic develop-
ment. This hypothesis is based on the comparison of the successive phases of the
inflammatory response, particularly in the mechanisms that regulate the earliest steps,
in amniote gastrulation (Figures 3 and 4).
Gastrulation is a developmental phase that delineates the three embryogenic germ
layers: Ectoderm, endoderm and mesoderm. Haeckel coined the term gastrulation
derived from the Greek word “gaste“, meaning stomach or gut, that transforms the
rather unstructural early embryo into a gastrula with several specific characteristics:
The three primary germ layers are formed; the basic body plan is established, including
the construction of the rudimentary body axes; and the cells assume new positions,
allowing them to interact with cells that were initially not close to them [134].
In essence, gastrulation could be represented as the creation of an interstitial space
that is successively infiltrated by molecules and cells, in a similar fashion as the inflam-
matory interstitium of the traumatized tissue. Therefore, during gastrulation, the extra-
embryonary mesodermis internalizes and occupies the space located between the
amnion and the yolk sac. The primitive streak is a subpopulation of the epiblast in the
organizing center for amniote gastrulation [135]. Once the initial primitive streak is
established, germ layer formation begins. At the primitive streak, the epiblast cells
undergo the epithelial-mesenchymal transition to form the primary mesenchyma
between the amnion and the yolk sac [136]. Afterwards, this is followed by mesenchy-
mal-epithelial transitions to create secondary epithelium as part of somitogenesis and
further commitment and diversification of cells forming mesoendodermal structures
[136,137]. The concept that fibroblasts are simple residual embryonic mesenchymal
cells explains the incorrect and often interchangeable substitution of the term “fibro-
blast” for “mesenchymal cell” [137].
The vast arrangement of the mesenchyme around and between the developing
amniotic and yolk sac cavities suggests an important role of the mesenchyma in
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orchestrating embryo development. Mesenchymal stem cells are a versatile group of
cells derived from mesodermal progenitors and can be found in several fetal and adult
tissues [138]. The amnion is comprised of two layers, an epithelial monolayer and a
stromal layer. From the human amnion it is possible to isolate two cell types, amniotic
epithelial cells, derived from the embryonic ectoderm, and amniotic mesenchymal stro-
mal cells, originating from the extraembryonic mesoderm [139,140]. Mesenchymal
stem cells isolated specifically from the amniotic membrane could differentiate into
neuronal-like cells which are identified to secrete dopamine [141]. Cells derived of
amniotic fluid also have a neuronal, dopaminergic phenotype [142]. These results allow
for considering the amnion as an embrionary functional axis with strong neural poten-
tial [141,142]. In addition, mesenchymal stem cells derived from the amnion are a
transplantable cell population with therapeutic potential for multiple central nervous
system disorders, especially stroke [140]. Experimental and clinical studies have
demonstrated that amniotic membrane transplantation has important biological prop-
erties including anti-inflammatory, anti-microbial, anti-fibrosis and anti-scarring, as
well as low immunogenicity. It also favors re-epithelialization [139,140]. Amnion-
derived multi-potent progenitor cells secrete a unique combination of cytokines and
growth factors, known as amnion-derived cellular cytokine solution, which establish a
communication network between mesenchymal and epithelial cells during embryo
development. That is why using the amnion to accelerate wound healing through its
functions has been proposed, which regulates migration, proliferation and differentia-
tion of fibroblast and keratinocytes [143].
The extraembryonic visceral yolk sac in mammals is composed of two layers and the
visceral endoderm, which is active in endocytosis/digestion and has large lysosomes
and the underlying mesoderm layer [144]. In the embryonic mesoderm layer “blood
islands” develop, supporting hematopoiesis and angiogenesis [36]. Also a major func-
tion of the yolk sac is associated with the accumulation of carbohydrates, proteins and
lipids for embryo nutrition (vitellum) [145]. Particularly, the yolk sac plays a vital role
in providing lipids and lipid-soluble nutrients to embryos during the early phases of
development [145,146]. The yolk sac uses high-density lipoproteins (HDL) and very
low-density lipoproteins (VLDL) as carriers to incorporate cholesterol from the mate-
rial circulation and to transfer it to the embryonic side [145]. Interstitial lipid accumu-
lation of cholesterol, a precursor molecule of many hormones, like aldosterone,
corticoides, androgens, strogens and progesterone, may favor fluid infiltration and cell
migration, proliferation and differentiation during embryo development [147].
The molecular and cellular contribution made by both embryo structures -the
amnion and yolk sac- to the interstitial space located between them, that is the meso-
derm, are essential for organogenesis. However, both in the amnion as in the yolk sac
structures, the extraembryonic mesenchyma plays an important role (Figure 4). It
could be assumed that both cavities, which are surrounded by epithelium, are con-
trolled by an array of inductive and inhibitory signals originating from the adjacent
extraembryonic mesenchyma. If so, the amnion wall, represented by the amniotic-
mesenchymal-epithelial unit, plays the leading role in primitive interstitial hydroelec-
trolitic changes [28,31] and favors the development of a rudimentary neurogenesis
[141,142]. In regards to the yolk sac wall, represented by the vitelline-mesenchymal-
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epithelial unit, it could exert functions fundamentally associated with hematopoiesis
and angiogenesis [32,37]. (Figure 9).
It could be accepted that these primitive functions are internalized during gastrula-
tion to create the mesoderm. Thus, this germ layer would integrate the amnion- and
yolk sac-related functions and would strengthen its functional ability compared to the
extraembryonic mesenchyma (Figure 9). Therefore, the epithelial cells located near the
dorsal midline of the neural tube undergo primary epithelial-mesenchymal transition
and differentiate into many diverse derivates including neurons of the peripheral ner-
vous system, glial cells and pigment cells, i.e. melanocytes [136,148]. In turn, the meso-
derm and the endoderm contribute cells to other tissues of the developing animal.
Thus, the yolk sac is an early source of hemangioblast, a common precursor of
endothelial and hematopoietic cell lineages, and the cells of the visceral endoderm con-
stitute a subpopulation of cells within the developing gut tube and therefore, have
functions involved in digestion [149-151] (Figure 10).
In the adult organism, many pathways that play an essential role during embryo
development are inactivated later in life although some of them may be transiently
expressed during adult repair [152]. This hypothetical ability of the tissues to involute
or dedifferentiate could be an effective defense mechanism against injury since it could
make retracing a well-known route using the appropriate mechanisms for their repair.
However, it is possible that the great dedifferentiation reached by the traumatized tis-
sues has been underestimated. That is why in the current review we have considered
that wound repair would require the upregulation of signaling pathways characteristic
of the extraembryonic mesenchymal function, as well as of its posterior embryonary
internalization during gastrulation. If so, emulation by the wounded tissue of the extra-
embryonic mesenchymal functions perhaps requires retracing the mechanisms that
produce and distribute the extracellular fluid, including the amniotic fluid. These
extraembryonic mesenchymal functions induce and regulate the neurogenic amniotic
phenotype and activate the yolk sac-lipid metabolism associated with hemangioblast
Figure 9 The amniotic embryo. The extraembryonic mesenchyma constitutes the walls of the amnion (A)
and the yolk sac (Y). During gastrulation it could be considered that the extraembryonic mesenchyma
internalizes with its functions: hydroelectrolitic control and neurogenesis in the amniotic side and
angiogenesis and hematopoiesis in the yolk sac side. The internalization of the extraembryonic
mesenchymal functions could integrate the amnion and the yolk sac original functions into the
intraembryonic mesenchyma. Nonetheless, during the inflammatory response, the dedifferentiation process
suffered by the tissues could re-express with clarity the primitive axes of the amnion and yolk sac.
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differentiation. It could be proposed that traces of these functions, based on stem cell
lineages, are developed in the early phases of the post-traumatic inflammatory response
(Figure 2) and would be expressed mainly in the interstitial space of the tissues
(Figures 6 and 7).
As in the gastrulation process, it is possible that the primitive functions of the extra-
embryonic mesenchyma, whose re-expression is induced by the wound, would be
internalized by the adult body. But, this mechanism would produce a serious loss of its
health. So, if embryonic developmental pathways, representative of its primitive life,
would re-emerge in the adult organism, they would take the place of post-natal specia-
lized functions, impeding or hindering its actual life.
Nonetheless, according to the proposed hypothesis, the failure of adult skin regenera-
tion after a wound suggests the need of researching those factors and mechanisms that
must be upregulated and those that must be reduced or even avoided to efficiently
reproduce the early embryonic conditions for development. Understanding the process
that gives rise to early embryonic development may lead to advances in wound thera-
pies. Perhaps, the mechanisms of scarless wound healing in the fetus are related to this
supposed ability to maintain the memory of their origin while undergoing
Figure 10 Schematic representation of the gastrulation process (top) and of a skin wound
(bottom). The hypothetical functional reactivation of embryonic development axes after a tissue injury
would reproduce the embryonic biochemical pathways in the mature organism. e: epiblast; eh: endothelial-
hematopoietic cell lineages; ep: epithelium; EMT/MET: epithelial mesenchymal transition/mesenchymal
epithelial transition; f: fibroblast; HP: hyperpigmentation; m: melanocyte; my: myofibroblast; n:neuron; nc:
neural crest cell; NI:neuronal inflammation; nt: neural tube; not: notochord; p: pericyte; skm: skeletal muscle;
v:blood vessels; VI: vascular inflammation;
Aller et al. Theoretical Biology and Medical Modelling 2010, 7:37
http://www.tbiomed.com/content/7/1/37
Page 22 of 32
reprogramming events that could allow them to re-enter the embryonic programs of
tissue formation to obtain the regeneration after injury [153,154].
Mast cells as executors of the pathological axis of inflammation: guardians when not
terrorist
Mast cells are ubiquitous in the interstitial spaces of the body and normally reside in
the connective tissue close to blood vessel nerves and epithelia [155]. Current evidence
suggests that mast cells exert their role, in all the inflammatory response phases, and
that is why they are an ideal candidate for playing a role in wound healing [156]
(Figure 10).
Particularly, mast cells could orchestrate the inflammatory response inducing the
expression of embryonic programs of tissue formation. Mast cells are derivatives of
hematopoietic progenitor cells that migrate into virtually all vascularized tissues, where
they complete their maturation. Upon activation their “plasticity” allows them greater
flexibility and diversity in term of responsiveness to meet the requirements of the
inflammatory response in which these cells are involved [155]. In this sense, activated
mast cells can induce the expression of the proposed neurovascular axes of the inflam-
mation. Thus, mast cells secrete numerous biogenic monoamines, i.e. histamine, sero-
tonin, and nociceptive molecules that can sensitize sensory neurons which further
activate mast cells by releasing neurotransmitter or neuropeptides, i.e. acetylcholine,
neurotensin, substance P and somatostatin [157,158]. Mast cells are also the source of
many biologically active mediators involved in the process of neovascularization
[155,159]. Mast cells are topographically associated with microvessels and their number
rises in angiogenesis-dependent events such as inflammation [159,160]. The role of
mast cells in angiogenesis is mediated by the release of their stored substances to a
variety of stimuli [155,160,161]. Mast cell mediators include histamine, chymases, cyto-
kine and growth factors like PDGF and VEGF, all of which exhibit pro-angiogenic
properties [159-162]. In addition, post-traumatic inflammation is a strong pro-hemato-
poietic stimulus. Mast cells are one of the cells that produce pro-inflammatory pleio-
tropic mediators that induce hematopoiesis [163]. Hematopoietic stem cells, in turn,
give rise to a hierarchically organized set of progenitors for erythroid, myeloid, lym-
phoid and megakaryocyte lineages [36]. Particularly, neutrophils, monocyte/macro-
phages and T cells from the bone marrow are always present in the interstitial
connective tissue during inflammatory response progression [17,21]. Mast cells infil-
trating injured tissues, through the release of granulocyte-macrophage colony stimulat-
ing factor (GM-CSF), can act on the bone marrow requesting the inflammatory cells
needed for repair. A polarized hematopoietic axis from the bone marrow up to the
mesenchymal interstitial space of the injured tissue would be established (Figure 10).
Mesenchymal post-traumatic dedifferentiation induced by activated mast cells could
favor the expression of extraembryonic mesenchymal associated functions. In this way,
embryonary mesenchymal functional axes are again expressed in the injured tissue,
favoring in turn neurogenesis, hematopoiesis and angiogenesis. But mast cells also
could simultaneously activate the mechanisms associated with gastrulation and this
would mean the internalization of the above mentioned mesenchymal functional axes.
In this developmental process, generation of the mesoderm from the ectoderm, that is
the epiblast, by epithelial to mesenchymal transition [164], is associated with
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mesoderm cell constriction, leading to invagination [115,116]. Therefore, it is not sur-
prising that during wound healing the excessive mesenchymal cell production and
matrix deposition predominate, as well as the coexistence of wound contraction, which
requires the presence of mast cells and contractile fibroblasts [156]. It is possible that
in the inflammatory responses in which mast cells predominate, i.e. allergic and auto-
immunes [165,166], this primitive embryonic mesenchymal response predominates.
This hypothetical comparison could help to better understand the pathophysiological
mechanisms and the histological characteristics that this type of chronic inflammatory
response develops, particularly, the type of bidirectional interactions established
between epithelial and mesenchymal phenotypes [165,167].
Mast cells could also participate in the worsening of the inflammatory response
when a noxious factor is associated [168]. Mast cells are components of the innate
immune system that acts as sentinels stationed around blood vessels, including swel-
ling, redness and leukocyte recruitment [169]. Histamine, serotonin, proteases and
VEGF stand out among the mediators released by mast cells, which cause vasodilation,
edema and exudation due to increased vascular permeability [155]. The persistence of
edema induced by mast cell mediators could maintain hypoxia in the wounded tissue
and consequently inflammation [120,169]. However, chronic interstitial edema could
also induce mesenchymal dedifferentiation. If so, mesenchymal fibroblasts embedded
in the interstitial fluid could migrate and preserve their proliferation potential.
Under conditions of long-lasting inflammation, wound healing is associated with
excessive interposition of fibrotic tissue. Prolonged inflammation in wounds contri-
butes to the development of fibroproliferative scars, in other words, keloids and hyper-
trophic scar, both with erithematous and increased mast cell density [101,102].
Interactions between mast cells and fibroblasts are paramount in the genesis of fibrosis
[168]. Fibrosis is characterized by excessive matrix deposition and reduced remodeling.
Often fibrotic lesions are associated with increased densities of mast cells [170]. It has
been shown that mast-cell secreted factors, specifically PDGF, could contribute to
inflammation-associated fibrosis, inducing the expression of osteopontin by wound
granulation tissue fibroblasts [171]. The fibroproliferative scars constitute solid cords
along the wound axis which are related to wound remodeling. This excessive stiffness
of the repair tissue resembles the notochord in the early embryo and, if so, it could be
an ancestral trace of the mesenchyme also related to gastrulation. Particularly, meso-
derm creation includes the development of a solid structure with great stiffness essen-
tial for correct morphogenesis, that is the notochord, and which is precisely what
dominates the chordates.
Growth factors pivotal for repair in mammalians are PDGF/VEGF. In general, fibro-
blasts could respond in a pathological fashion to PDGF/VEGF promoting fibrotic tissue
scarring [17]. Inflammatory cells, such as activated macrophages and mast cells, can
produce inflammatory mediators that promote up-regulation of PDGF receptors on
mesenchymal cells. As a result, PDGF-mediated proliferation of mesenchymal cells
may be a hallmark of all chronic inflammation [172]. However, important developmen-
tal roles for PDGF and their receptor-like proteins have also been demonstrated in
mammalian and non-mammalian vertebrates. Several observations suggest that PDGF
has early developmental functions, particularly during gastrulation. PDGF receptors
expression occurs in the developing mesoderm, mediating mesoderm cell migration,
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thus when the PDGF receptor is inhibited, the mesodermal cell detaches from the
ectoderm and undergoes apoptosis [172,173]. PDGF signaling has an evolutionary con-
served role during gastrulation and it has been implicated in neural and functional
development as well as in the early differentiation of hematopoietic/endothelial precur-
sor [172].
If we hypothesize that during wound healing a process similar to the embryonic gas-
trulation with internalization of the primitive extraembryonic functions is developed,
we could deliberate about the original nature of these functions and their correspond-
ing mediators. Therefore, it could turn to the mast cell functions and mediators
because of its ubiquity during all the phases of the inflammatory response [156]. Mast
cells are able to take up, store and release a variety of biogenic amines through which
it is hypothesized that they participate in inflammatory reactions, mainly monoamines
like histamine and serotonin [157]. These monoaminergic systems play a variety of
roles in animals as neurotransmitters, autocrine and paracrine factors and hormones.
However, also the venoms of many different animals, i.e. coelenterates, octopus, scor-
pions, centipedes, insects, amphibians and snakes contain histamine, in addition to
other monoamines [174]. Also, the most ubiquitous effect of venoms on monoaminer-
gic systems is venom-induced release of histamine from mast cells [174,175].
Likewise, the venoms of some species of coelenterates, octopus, spiders, scorpion,
cone snails, centipedes, insects, amphibians and snakes contain serotonin [174]. It is
thought that the most common function of both histamine and serotonin in venom is
to produce pain and paralysis in the prey. Therefore, histamine and serotonin, charac-
teristic mast cells mediators, are venom developed for both offensive and defensive
purposes [174,175].
Examination of the effects of venoms on monoaminergic systems points out the great
diversity of venom effects and also the cases of evolutionary convergence. For example,
the venoms of scorpions, spiders and jellyfish cause a catecholamine storm in the vic-
tim [174,176-178].
A common feature of the Phylum Cnidaria, i.e. hydroids, anemones, corals and jelly-
fish, are tentacles with stinging cells, i.e. nematocytes or cnidocytes, which contain a
nematocyst discharge mechanism. The nematocyst neurotoxins can paralyze and often
kill the small prey, which are their food [178,179]. Both mechanical and chemical sti-
muli cause nematocysts to be discharged suggesting the involvement of both chemore-
ceptors and mechanoreceptors in the discharge process [179].
It is possible that during the evolution, these invertebrate armaments -defensive and
offensive- were internalized into in the mesenchyma. If so, an evolutive advantage was
associated with the risk of self-poisoning when the body suffered an injury that caused
the cells to be stuffed with toxic products, i.e. the mast cells. Even psychological stress
[180] because of the mutual association between mast cells and nerves [157] is a
potential cause of mast cell inflammatory activation [155]. Interactions between the
nervous system and the immune system, i.e. mast cells, are increasingly recognized as
important in the pathophysiology of inflammation, including itch [181].
Mast cells exhibit phenotypical and functional heterogeneity in different anatomical
sites [155]. Two types of mast cells have been identified in rodents, connective tissue-
type mast cells (CTMC) and mucosal mast cells (MMC) [155,182]. Particularly, fetal
skin-derived mast cells had many characteristic features of CTMC [182]. Mast cells are
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being preferentially localized at host-environment interface [155], although it is also
accepted that they occupy strategic locations with respect to the basic structural divi-
sion of the tissues and organs in the parenchyma, i.e. MMC and stroma, i.e. CTMC.
This distribution suggests the involvement of the mast cell subtypes in the differentia-
tion of the tissue structure. Perhaps thanks to these privileged locations in organs and
tissues, mast cells may participate in the pathogenesis of a wide array of diseases,
including allergic, inflammatory, angiogenic and fibrotic diseases [163,168,182]. In
these anatomical locations mast cells, as interstitial cells, could exert a key role in
modulating the epithelial-mesenchyma interaction, both in the physiological as in the
pathological status (Figure 11).
Conclusion
The ability of the tissues to involute or dedifferentiate could represent a return to early
stages of development. Therefore, it could form an effective defense mechanism to
escape death after injury since it could make retracing a well-known route possible, i.e.
the initial phases of embryonic development during the evolution of the inflammatory
response. Particularly, the up-regulation of signaling pathways during gastrulation, in
which the internalization of extraembryonary functions would be made, could help
explain the meaning of the diverse and complex mechanisms expressed by the mature
organism in response to skin injury.
If so, even the embryonary mechanisms to generate pigment cells could be responsi-
ble of the post-inflammatory hyperpigmentation with higher concentrations of melano-
cytes [183,184]. Nowadays, the underlying mechanisms and the individual variability
showed for developing post-inflammatory hyperpigmentation are not well understood
[184,185].
Figure 11 Mast cell key role in orchestrating the inflammatory axis. Upon activation, mast cells could
induce the expression of both inflammatory axes, the neurovascular axis and the mesenchymal axis.
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This amazing property of the cells to conserve a memory of their origin undergoing
reprogramming events could allow them, post-injury, to re-enter the embryonic pro-
grams of tissue formation and obtain regeneration [186]. Generally, while the monopo-
tent and tissue-committed stem cells were described in the adult tissue, stem cells with
a pluripotent/multipotent capacity were thought to be restricted to the early embryonic
stages. However, recent evidence challenged this idea by confirming the presence of
pluripotent/multipotent stem cells in adult tissues and organs [39]. Particularly, adult
human mesenchymal cell populations, such as skin fibroblasts, contain distinctly multi-
potent stem cells. These stem cells have the ability to generate the multiple cell types
of the three germ layers, like ectodermal (e.g. neural marker-positive cells), endodermal
and mesodermal lineage cells [187].
Interestingly enough, quiescent and active adult stem cells coexist in several tissues
that have the ability to renew and regenerate, like bone marrow, intestinal epithelium
and hair follicles, all of them placed in the vicinity of a mesenchymal cell [188]. This
stem cell-mesenchymal cell relation takes us back to the initial epiblast mesoderm rela-
tionship during gastrulation [36]. Thus, during vertebrate gastrulation, the cell behavior
is strictly coordinated in time and space by various signaling pathways. In vertebrates,
the non-canonical Wnt/planar cell polarity (Wnt/PCP) pathway is a key regulator of
convergence and extension movements, also involved in the internalization of meso-
dermal cells and their migration [189]. The name Wnt is derived from a combination
of two homologous genes; Wg (the Drosophila wingless gene) and Int (the murine
homologue mouse mammary tumor virus integration site 1 gene) [190]. Wnt repre-
sents a large morphogenic family of secreted lipid-modified glycoproteins that during
embryogenesis controls multiple developmental processes [189,190] and during adult
life regulates tissue maintenance and remodeling [188,190]. At the cellular level, Wnt
signals coordinate changes in cellular metabolism favoring either a “quiescent metabo-
lism” or a “proliferating metabolism” [188,190]. This is why it is tempting to speculate
that common alterations in metabolic programming may accompany embryonic and/or
stem cell differentiation and these may also be involved in adult tissue development
and/or remodeling [190].
In summary, the post-traumatic inflammatory response could be considered a reac-
tion of the body in which the mesenchymal cell plays a leading role during which the
early events of embryonic development and particularly gastrulation are recreated. The
mesenchymal cell due to its strategic and privileged location in the interstitial space, is
able to induce the successive phases of inflammation. Therefore, the mesenchymal cell
uses the mast cell, to induce the expression of neurovascular inflammatory axes that
have an extensive corporal projection and whose activity converges in the wounded
skin.
The correlation that can be established between the embryonic and inflammatory
post-traumatic events suggests that the results obtained from the research about both
great fields of knowledge must be interchangeable to obtain the maximum advantage
in the daily care of patients’ wounds.
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